Effects of enhanced bolus flavors on oropharyngeal swallow in patients treated for head and neck cancer

Background Treatment for head and neck cancer can reduce peripheral sensory input and impair oropharyngeal swallow. This study examined the effect of enhanced bolus flavor on liquid swallows in these patients. Methods Fifty‐one patients treated for head and neck cancer with chemoradiation or surgery...

Full description

Saved in:
Bibliographic Details
Published inHead & neck Vol. 35; no. 8; pp. 1124 - 1131
Main Authors Roa Pauloski, Barbara, Logemann, Jerilyn A., Rademaker, Alfred W., Lundy, Donna, Sullivan, Paula A., Newman, Lisa A., Lazarus, Cathy, Bacon, Mary
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.08.2013
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1043-3074
1097-0347
1097-0347
DOI10.1002/hed.23086

Cover

More Information
Summary:Background Treatment for head and neck cancer can reduce peripheral sensory input and impair oropharyngeal swallow. This study examined the effect of enhanced bolus flavor on liquid swallows in these patients. Methods Fifty‐one patients treated for head and neck cancer with chemoradiation or surgery and 64 healthy adult control subjects served as subjects. All were randomized to receive sour, sweet, or salty bolus flavor. Patients were evaluated at 7–10 days, 1 month, and 3 months after completion of tumor treatment. Control subjects received 1 assessment. Results All bolus flavors affected oropharyngeal swallow; sour flavor significantly shortened pharyngeal transit time across all evaluations. Conclusions Sour flavor influenced the swallow of patients treated for head and neck cancer, as well as that of control subjects in a manner similar to those with neurologic impairment observed in an earlier study. Sour flavor may improve the speed of pharyngeal transit regardless of whether a patient has suffered peripheral or central sensory damage. © 2012 Wiley Periodicals, Inc. Head Neck, 2013
Bibliography:ArticleID:HED23086
NIH/NCI - No. P01 CA40007
istex:8BBED533D3ED22DE3E2FD7E3AD62FB939BDDE58B
ark:/67375/WNG-XGBCLKZX-T
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
Dr. Sullivan is currently at Malcom Randall Veterans Health Care System, Gainesville, FL.
Dr. Newman is currently at National Center for Research Resources, National Institutes of Health, Bethesda, MD.
Dr. Lazarus is currently at Beth Israel Medical Center, New York, NY.
Dr. Bacon is currently at Rush University Medical Center, Chicago, IL.
ISSN:1043-3074
1097-0347
1097-0347
DOI:10.1002/hed.23086